Literature DB >> 7263062

Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins.

F X Heinz, W Tuma, C Kunz.   

Abstract

Polymeric, delipidated glycoprotein complexes of defined size and composition were prepared from tick-borne encephalitis virus by solubilization with Triton X-100 or cetyltrimethylammonium bromide, followed by centrifugation into detergent-free sucrose density gradients. The antigenic reactivities and immunogenicities of these complexes were compared with those of complete inactivated virus. These glycoprotein preparations induced hemagglutination-inhibiting and neutralizing antibodies which proved to be protective in passive mouse protection tests and monospecifically reacted only with the viral envelope and not with the internal core. In a competitive radioimmunoassay the glycoprotein complexes revealed about 10-fold higher antigenicity than whole virus when tested at equal protein concentrations. The important implications of these results with respect to antigen quantification in vaccines are discussed. As shown in the mouse challenge potency test, glycoprotein complexes prepared after Triton X-100 solubilization actively protected mice almost as well as did complete inactivated virus at the same protein concentration, whereas those prepared after cetyltrimethylammonium bromide solubilization had a somewhat lower protective activity per microgram of protein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263062      PMCID: PMC350683          DOI: 10.1128/iai.33.1.250-257.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Solubilization of membranes by detergents.

Authors:  A Helenius; K Simons
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Formation of protein micelles from amphiphilic membrane proteins.

Authors:  K Simons; A Helenius; K Leonard; M Sarvas; M J Gething
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

4.  Isolation of the dengue virus envelope glycoprotein from membranes of infected cells by concanavalin A affinity chromatography.

Authors:  S A Stohlman; O R Eylar; C L Wisseman
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

5.  Immune response in rabbits to virion and nonvirion antigens of the Flavivirus kunjin.

Authors:  A J Della-Porta; E G Westaway
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

6.  Effective subunit vaccines against an enveloped animal virus.

Authors:  B Morein; A Helenius; K Simons; R Pettersson; L Kääriäinen; V Schirrmacher
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

Review 7.  The regulatory role of macrophages in antigenic stimulation.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

8.  Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing.

Authors:  D W Trent
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

9.  Isolation of dimeric glycoprotein subunits from tick-borne encephalitis virus.

Authors:  F X Heinz; C Kunz
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

10.  Dissociation of tick-borne encephalitis virus by Triton X-100 and cetyltrimethylammonium bromide.

Authors:  F Heinz; C Kunz
Journal:  Acta Virol       Date:  1979-05       Impact factor: 1.162

View more
  10 in total

1.  The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization.

Authors:  F X Heinz; C W Mandl; H Holzmann; C Kunz; B A Harris; F Rey; S C Harrison
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.

Authors:  T R Kreil; E Maier; S Fraiss; M M Eibl
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model.

Authors:  T R Kreil; M M Eibl
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Comparative study of infectious and formaldehyde-inactivated tick-borne encephalitis virus particles.

Authors:  I V Krasilnikov; L B Elbert; M K Khanina; S G Sobolev
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.

Authors:  R Ralston; K Thudium; K Berger; C Kuo; B Gervase; J Hall; M Selby; G Kuo; M Houghton; Q L Choo
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  Monoclonal antibodies to the structural glycoprotein of tick-borne encephalitis virus.

Authors:  F X Heinz; R Berger; O Majdic; W Knapp; C Kunz
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report.

Authors:  R J Phillpotts; J R Stephenson; J S Porterfield
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Pathogenesis and immune response of vaccinated and unvaccinated rhesus monkeys to tick-borne encephalitis virus.

Authors:  P Hambleton; J R Stephenson; A Baskerville; C N Wiblin
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Characterization of two Japanese encephalitis virus strains isolated in Thailand.

Authors:  A Ali; A Igarashi; L R Paneru; F Hasebe; K Morita; M Takagi; W Suwonkerd; Y Tsuda; Y Wada
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody.

Authors:  T Trirawatanapong; B Chandran; R Putnak; R Padmanabhan
Journal:  Gene       Date:  1992-07-15       Impact factor: 3.688

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.